Axogen Inc
USUSDAxogen Inc (LSE:0HKD) — Biotechnology: Electromedical & Electrotherapeutic Apparatus. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 2. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.
Über das Unternehmen
- Website
- axogeninc.com
- Investor Relations
- ir.axogeninc.com/
- Sektor
- Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Hauptsitz
- ALACHUA, United States
- CEO
- Michael D. Dale
- Mitarbeiter
- 622
- Börsennotiert seit
- 29.01.2018 (LSE:0HKD)
- Ausstehende Aktien
- 58.67 Mio. Stand 2026-07-27
- Streubesitz
- 49.06 Mio.
- Marktkapitalisierung
- 2.12 Mrd. USD
- Insider
- 1.98%
- Institutionelle Anleger
- 98.6%
- Branche (SIC)
- Electromedical & Electrotherapeutic Apparatus
- FCF
- 8.60 Mio. USD
- Schulden
- 0 USDNettoliquidität
- Gewinne und FCF – für die 12 Monate bis 30.06.2026 (aktueller Bericht des Unternehmens).
Beschreibung
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.
Neuigkeiten diese Woche
Keine Nachrichten in der letzten Woche. Neueste Nachrichten: 01.10.2026.
Größte Anteilseigner
| Inhaber | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| Blackrock Inc. | 8.22% | 4.42 Mio. | 2026-06-30 |
| First Light Asset Manage… | 5.11% | 2.75 Mio. | 2026-06-30 |
| Morgan Stanley | 5.11% | 2.75 Mio. | 2026-06-30 |
| Vanguard Capital Managem… | 4.2% | 2.26 Mio. | 2026-06-30 |
| Artemis Investment Manag… | 3.31% | 1.78 Mio. | 2026-09-30 |
| VANGUARD INDEX FUNDS-Van… | 2.97% | 1.6 Mio. | 2026-06-30 |
| Polar Capital Holdings P… | 2.79% | 1.5 Mio. | 2026-06-30 |
| Wellington Management Gr… | 2.59% | 1.39 Mio. | 2026-06-30 |
| Geode Capital Management… | 2.56% | 1.38 Mio. | 2026-06-30 |
| Citadel Advisors Llc | 2.53% | 1.36 Mio. | 2026-06-30 |
| iShares Trust-iShares Ru… | 2.52% | 1.35 Mio. | 2026-08-31 |
| Wasatch Advisors LP | 2.41% | 1.3 Mio. | 2026-06-30 |
| Manager Directed Portfol… | 2.04% | 1.1 Mio. | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 1.13% | 609 728 | 2026-06-30 |
| T. Rowe Price New Horizo… | 1.09% | 588 200 | 2026-06-30 |
| Fidelity Salem Street Tr… | 1.07% | 575 481 | 2026-07-31 |
| BARON INVESTMENT Fd.S TR… | 0.99% | 532 900 | 2026-06-30 |
| Fidelity Capital Trust-F… | 0.98% | 526 000 | 2026-07-31 |
| iShares Trust-iShares Ru… | 0.92% | 493 391 | 2026-08-31 |
| Vanguard Explorer Fund | 0.8% | 428 087 | 2026-07-31 |
| DEVINNEY ERICK WAYNE (Of… | ≈0.49% | 262 781 | 2026-03-16 |
| MCBRIDE-WENDELL AMY A. (… | ≈0.2% | 107 976 | 2026-08-11 |
| QUACKENBUSH DORIS (Offic… | ≈0.17% | 92 416 | 2026-05-07 |
| NEELS GUIDO J (Director) | ≈0.16% | 86 743 | 2025-06-09 |
| KEMP JENS SCHROEDER (Off… | ≈0.13% | 72 451 | 2026-05-07 |
| HARTLEY LINDSEY MARIE (C… | ≈0.12% | 65 146 | 2026-05-07 |
| DALE MICHAEL D (Chief Ex… | ≈0.12% | 63 537 | 2025-12-10 |
| LEVINE ALAN M. (Director… | ≈0.09% | 50 893 | 2026-06-18 |
| BEGAN MARC A. (General C… | ≈0.09% | 50 135 | 2026-08-10 |
| THOMAS PAUL G (Director) | ≈0.06% | 32 395 | 2026-06-18 |